Genovese Burford & Brothers Wealth & Retirement Plan Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$321K Sell
2,995
-110
-4% -$10.6K 0.08% 79
2020
Q3
$272K Buy
3,105
+157
+5% +$14.8K 0.08% 76
2020
Q2
$289K Buy
2,948
+193
+7% +$17K 0.08% 62
2020
Q1
$210K Buy
+2,755
New +$235K 0.06% 84
2018
Q4
Sell
-2,625
Closed -$248K 87
2018
Q3
$248K Sell
2,625
-10
-0.4% -$948 0.08% 76
2018
Q2
$244K Hold
2,635
0.09% 66
2018
Q1
$249K Sell
2,635
-45
-2% -$4.94K 0.09% 64
2017
Q4
$301K Buy
2,680
+17
+0.6% +$1.6K 0.79% 26
2017
Q3
$236K Hold
2,663
0.1% 51
2017
Q2
$193K Buy
2,663
+3
+0.1% +$202 0.08% 58
2017
Q1
$174K Sell
2,660
-186
-7% -$11.7K 0.07% 62
2016
Q4
$179K Sell
2,846
-192
-6% -$11.7K 0.05% 73
2016
Q3
$191K Sell
3,038
-400
-12% -$25.9K 0.08% 60
2016
Q2
$212K Buy
3,438
+1,000
+41% +$60.9K 0.09% 55
2016
Q1
$139K Hold
2,438
0.07% 70
2015
Q4
$144K Buy
+2,438
New +$140K 0.07% 65

Other funds holding ABBV

Genovese Burford & Brothers Wealth & Retirement Plan Management's ABBV Position: Q4 2020 in Review

Genovese Burford & Brothers Wealth & Retirement Plan Management reduced its AbbVie (ABBV) stake by 3.5% in Q4 2020, selling an estimated $10.6K and leaving 2,995 shares worth $321K. The position accounts for 0.08% of the portfolio, ranked #79.

Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in ABBV in Q4 2015 and has held it in 16 quarters since. 2,598 funds tracked by Wall St. Rank hold ABBV as of Q4 2020.

  • Genovese Burford & Brothers Wealth & Retirement Plan Management held 2,995 shares of AbbVie worth $321K as of Q4 2020.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management sold 110 AbbVie shares in Q4 2020, an estimated $10.6K.
  • AbbVie made up 0.08% of Genovese Burford & Brothers Wealth & Retirement Plan Management's portfolio in Q4 2020, its #79 holding.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in AbbVie in Q4 2015 and has held it in 16 quarters since.
  • 2,598 funds tracked by Wall St. Rank held AbbVie as of Q4 2020.

Based on Genovese Burford & Brothers Wealth & Retirement Plan Management's 13F filing for Q4 2020, filed 5 Feb 2021.